3John Bradley, Jim McCluskey.Clinical Immunology[M]. OXford: Oxford University Press,1997.164.
4Crump M, Gospodarowicz M,Shepherd FA. Lymphoma of the gastrointestinal tract[J].Semin-Oncol,1999,26(3):324-337.
5Gurney KA, Cartwright RA, Gilman EA. Descriptive epideminology of gastrointestinal non-Hodgkin lymphoma in a population-based registry[J]. Br-J-Cancer,1999,79(11-12):1929-1934.
6Fischbach W. Helicobacter and lymphoma[J].Chirurg,1998,69(3):249-251.
7Koss LG, Woyke S, Olszewski W. AspirationalBiopsy-Cytologic Interpretation and Histologic Bases [M]. New York, Tokyo: I-gaku-Shoin, 1992. 220-221.
8Ribatti D,Vacca RD,Nico B,et al.Angiogenesis spectruma in the stroma of B-cell non-Hodgkin's lymphomas.An immunohistochemical and ultrastructural study[J].Eur J Haematol,1996,56(1-2):45-53.
9Foss HD,Araujo I,Demel G,et al.Expression of vascular end othelial growth factor in lymphomas and Castleman's disease[J].J Pathol,1997,183(1):44-50.
10Salven P,Teerenhori L,Joensue H.A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcom in non-Hodgkin's lymphoma[J].Blood,1997,90(8):3167-3172.
